The Ambivalence of Cytostatic Therapy

- Ambivalence of Cytostatic Therapy

af

indgår i serie RECENT RESULTS IN CANCER RESEARCH


The Ambivalence of Cytostatic Therapy
Du sparer Spar kr. 30,00 med Saxo Premium
  • Leveringstid 2-4 uger
  • Forventet levering 24-03-2020
Hvis du køber til medlemspris, bliver du automatisk medlem af Saxo Premium. De første 30 dage er gratis, derefter koster det 99,-/md. Medlemskabet fornyes automatisk og kan altid opsiges. Læs mere om alle fordelene her.
Format:
Bog, paperback
Udgivelsesdato:
16-01-2012
Sprog:
Engelsk
Udgave:
Softcover reprint of the original 1st ed. 1975.
  • Beskrivelse
  • Yderligere info
  • Anmeldelser

E. GRUNDMANN The question as to whether cytostatic drugs might be carcinogenic has been presented and discussed in three experimental studies. The most extensive in- vestigations were by J. H. WEISBURGER and coll. (New York, Alabama, Bethesda). They started with an exact determination of rate and localization for spon- . taneous tumors in their animal strains. Thirteen cytostatic compounds current- ly in clinical use were then given in the maximally tolerated dose (MTD) to groups of 25 male and 25 female animals (rats and mice) three times weekly, in most assays over a period of 6 months. Other identical groups of animals received 0. 5 of the MTD. Each test involved 50 male and 50 female mice and the same number of rats. As positive controls, identical groups were given diethylnitrosamine, which induced tumors of liver, lungs and kidneys in the expected rates. The direct alkylating agents (Actinomycin 0, Melphalan, Mito- mycin 0, Uracil mustard, Dibromomannitol and Dibromodulcitol) induced cancer in the peritoneal cavity, the site of the injections. Rats appeared to be more susceptible than mice. Other drugs (e. g. the cyclohexamide salt of phos- phorodiamidic acid derivative, Natulan, DIC and streptozotocin) had a broad spectrum of carcinogenicity affecting a variety of organs.Several agents led to tumors in the hematopoietic and lymphatic systems in mice or rats or both. The correlation to the general immunosuppressive action is not quite clear. 6-Mercaptopurine induces lymphosarcomas in mice.

Vis mereVis mindre

Udgivelsesdato:
16-01-2012
ISBN13:
9783642809422
Vægt:
455 g
Dybde:
14 mm
Bredde:
170 mm
Højde:
244 mm
Nummer i serien:
52
Nummer i serien:
52
Format:
Paperback
Forfattere
Bibliotekernes beskrivelse Gesellschaft zur Bekampfung der Krebskrankheiten, Nordrhein- Westfalen e.V. and European Organization for Research on Treatment of Cancer. 5. Symposium in Dusseldorf, November 8, 9, 1973 1 Paperback / softback 20 Illustrations, black and white; VIII, 246 p. 20 illus.

Vis mereVis mindre

Vis mereVis mindre

Fandt du ikke hvad du søgte?

Hvis denne bog ikke er noget for dig, kan du benytte kategorierne nedenfor til at finde andre titler. Klik på en kategori for at se lignende bøger.

Velkommen til Saxo - din danske boghandel!

Hos os kan du handle som Gæst, Saxo-bruger eller Saxo Premium-medlem. Du bestemmer selv, og vores kundeservice sidder altid klar med hjælp.

Om medlemspriser hos Saxo

Hvis du køber til medlemspris, bliver du automatisk medlem og får del i de mange fede fordele. De første 30 dage er gratis for nye brugere, og derefter koster det kun 99,-/md. Medlemskabet fornyes automatisk, og du kan altid opsige det. Læs mere om fordelene ved Saxo Premium her.

Machine Name: SAXO032